Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,975Revenue $M2,129Net Margin (%)15.1Z-Score6.5
Enterprise Value $M9,150EPS $2.0Operating Margin %18.0F-Score7
P/E(ttm))25.4Cash Flow Per Share $0Pre-tax Margin (%)19.6Higher ROA y-yN
Price/Book5.310-y EBITDA Growth Rate %28.2Quick Ratio1.4Cash flow > EarningsY
Price/Sales3.85-y EBITDA Growth Rate %79.4Current Ratio1.9Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %3.0ROA % (ttm)12.5Higher Current Ratio y-yY
Dividend Yield %0.5Insider Buy (3m)0ROE % (ttm)22.9Less Shares Outstanding y-yY
Payout Ratio %13.0Shares Outstanding M170ROI % (ttm)0Gross Margin Increase y-yY

Gurus Latest Trades with RDY

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
RDYKen Fisher 2014-06-30 Add0.13%$38.67 - $46.08
$ 52.6825%Add 62.43%3,773,114
RDYKen Fisher 2014-03-31 Add0.08%$39.5 - $47.4
$ 52.6822%Add 56.3%2,322,863
RDYKen Fisher 2013-06-30 Add0.04%$32.98 - $38.7
$ 52.6844%Add 48.42%1,283,605
RDYKen Fisher 2013-03-31 Add0.02%$32.03 - $36.57
$ 52.6854%Add 31.46%864,830
RDYKen Fisher 2012-09-30 Buy 0.05%$28.94 - $32.58
$ 52.6875%New holding, 604555 sh.604,555
RDYBrian Rogers 2007-09-30 Sold Out -0.33%$15.25 - $16.85
$ 52.68227%Sold Out0
RDYBrian Rogers 2007-06-30 Buy 0.33%$15.25 - $17.25
$ 52.68223%New holding, 4250000 sh.4,250,000
RDYMohnish Pabrai 2006-09-30 Sold Out -1.11%$13.55 - $16.04
$ 52.68244%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RDY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
RDY Ken Fisher 2014-12-314,153,5722.440.43+3.97%
Premium Most recent portfolio changes are included for Premium Members only!

RDY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about RDY :

    Quarterly/Annual Reports about RDY:

      News about RDY:

      Articles On GuruFocus.com
      Emerging Market Stocks To Watch Out For Feb 17 2015 
      Should You Buy Actavis? Mar 18 2014 
      Dr. Reddy’s Laboratories: Should Continue to Gain Market Share in Lucrative Markets May 25 2012 
      5 Mid-Cap Healthcare Dividend Stocks with Perfect Earnings Growth Dec 05 2011 
      Abbott Laboratories and the “India Cure” for the Ailing Pharmaceutical Industry May 26 2010 
      Dr. Reddy’s Q3 FY09 Revenue at Rs. 18,401 million, EBITDA at Rs. 3,453 million, PAT at Rs. 1,924 m Jan 20 2009 

      More From Other Websites
      Toxic Stocks: It's Time to Sell These 5 Blue-Chip Laggards Feb 20 2015
      As Indian Market Roars Ahead, Skeptic Questions GDP Growth Feb 19 2015
      Dr. Reddy’s Q3 FY15 Financial Results Q3 FY15 Revenues at Rs.38.4 billion Q3 FY15 EBITDA at Rs.... Feb 12 2015
      Dr. Reddy's (RDY) Q3 Earnings Down 7% Y/Y, Revenues Up - Analyst Blog Jan 30 2015
      Dr. Reddy's (RDY) Stock Gained Today on Earnings Beat Jan 29 2015
      Dr. Reddy’s Q3 and 9 Months FY15 Financial Results Jan 29 2015
      Dr. Reddy’s Q3 and 9 Months FY15 Financial Results Jan 29 2015
      Curis (CRIS) in Focus: Stock Adds 17.5% in Session - Tale of the Tape Jan 23 2015
      Curis Up on Immuno-Oncology Agreement with Aurigene - Analyst Blog Jan 22 2015
      To Your Health: Pharma Stock Picks In China, India For 2015 Jan 22 2015
      Curis aims for anti-cancer drugs that use the immune system and come in a pill Jan 22 2015
      Dr. Reddy's to Release Q3 FY15 Results on January 29, 2015 Jan 22 2015
      Dr. Reddy's to Release Q3 FY15 Results on January 29, 2015 Jan 22 2015
      As India Market Surges: In Defense of Lofty Valuations Jan 21 2015
      Curis and Aurigene Announce Collaboration, License and Option Agreement to Discover, Develop and... Jan 21 2015
      India Climbs To Another Record -- Getting Expensive? Jan 21 2015
      Two Banks, Four ETFs Surge As India Cuts Lending Rate Jan 15 2015
      Can India Stocks Top Most World Markets This Year? Jan 08 2015
      Pharma Sales Growth In Emerging Markets Could Top 8%, Margins Need To Improve Jan 06 2015
      Rate Cuts, Reform on Tap in Asia for 2015 Dec 27 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial